Verition Fund Management LLC Catalyst Pharmaceuticals, Inc. Transaction History
Verition Fund Management LLC
- $16.5 Billion
- Q2 2024
A detailed history of Verition Fund Management LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 24,055 shares of CPRX stock, worth $474,605. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,055Holding current value
$474,605% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding CPRX
# of Institutions
286Shares Held
96.6MCall Options Held
29.2KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$369 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$180 Million2.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$160 Million0.0% of portfolio
-
State Street Corp Boston, MA6.03MShares$119 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3MShares$59.2 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.03B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...